secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001493152-24-003071
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Dare Bioscience receives Nasdaq delisting notice for bid price below $1.00 per share
--------------------------------------------------------------------------------

- Received Nasdaq delisting notice on Jan 17, 2024 for failing to meet minimum $1.00 bid price requirement.
- Company had until Jan 16, 2024 to regain compliance but did not.
- Will request a hearing before Nasdaq Hearing Panel to appeal and stay delisting.
- Hearing typically scheduled 30-45 days after request; no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315224003071/0001493152-24-003071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315224003071/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-003071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer